Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LASMIDITAN vs LATISSE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LASMIDITAN vs LATISSE: Safety Overview

Metric LASMIDITAN LATISSE
Total FAERS Reports 927 980
Deaths Reported 12 0
Death Rate 1.3% N/A
Hospitalizations 23 0
Average Patient Age 47.0 yrs 53.0 yrs
% Female Patients 85.4% N/A
FDA Approval Date Dec 18, 2020 N/A
Manufacturer Eli Lilly and Company N/A
Route ORAL N/A
Marketing Status Prescription N/A